{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:54:57Z","timestamp":1762145697744,"version":"build-2065373602"},"reference-count":67,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:00:00Z","timestamp":1631836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of the novel respiratory disease COVID-19, has reached pandemic status and presents a wide range of manifestations of diverse magnitude, including fever, cough, shortness of breath, and damage to vital organs, such as the heart, lung, kidney, and brain. Normally, older individuals and those with underlying health issues are more at risk. However, about 40% of COVID-19 positive individuals are asymptomatic. This review aims to identify suggested mechanisms of diverse manifestations of COVID-19. Studies suggest that T cell-mediated immunity and specific and\/or nonspecific immunity from other vaccines could protect against SARS-CoV-2. The potential role of cross-reacting antibodies to coronaviruses that cause the common cold, mumps virus, polio virus, and pneumococcal bacteria are also suggested to help protect against COVID-19. Decreased production of Type I interferons (IFN-\u03b1 and IFN-\u03b2) could also be linked to COVID-19 manifestations. Several studies suggest that ACE2 cell membrane receptors are involved in SARS-CoV-2 infection. However, the relationship between an abundance of ACE2 receptors and the infectivity of the virus is unknown. Unlocking these manifestation mysteries could be crucial as this could help researchers better understand the virulence, pathology, and immune responses associated with SARS-CoV-2, leading to the development of effective therapies and treatment plans.<\/jats:p>","DOI":"10.3390\/ijerph18189785","type":"journal-article","created":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T21:23:29Z","timestamp":1631913809000},"page":"9785","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Diverse Manifestations of COVID-19: Some Suggested Mechanisms"],"prefix":"10.3390","volume":"18","author":[{"given":"Md S.","family":"Zaman","sequence":"first","affiliation":[{"name":"Department of Biological Sciences, Alcorn State University, Lorman, MS 39096, USA"},{"name":"Department of Biology, South Texas College, McAllen, TX 78501, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert C.","family":"Sizemore","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, Alcorn State University, Lorman, MS 39096, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,17]]},"reference":[{"key":"ref_1","first-page":"8478","article-title":"Human Coronavirus-229E, -OC43, -NL63, and -HKU1 Reference Module in Life","volume":"90","author":"Liu","year":"2020","journal-title":"Science"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.3389\/fmicb.2020.01800","article-title":"Geographic and Genomic Distribution of SARS-CoV-2 Mutations","volume":"11","author":"Mercatelli","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref_3","unstructured":"CSSE (Center for Systems Science and Engineering) (2021, September 03). Tracking COVID-19. Available online: https:\/\/www.arcgis.com\/apps\/opsdashboard\/index.html#\/bda7594740fd40299423467b48e9ecf6."},{"key":"ref_4","unstructured":"Institute for Health Metrics and Evaluation (IHME) (2021, September 04). Estimation of Excess Mortality Due to COVID-19. Available online: http:\/\/www.healthdata.org\/special-analysis\/estimation-excess-mortality-due-covid-19-and-scalars-reported-covid-19-deaths."},{"key":"ref_5","unstructured":"Couzin-Frankel, J. (2020, December 23). From \u2018Brain Fog\u2019 to Heart Damage, COVID-19\u2032s Lingering Problems Alarm Scientists. Available online: https:\/\/www.sciencemag.org\/news\/2020\/07\/brain-fog-heart-damage-covid-19-s-lingering-problems-alarm-scientists."},{"key":"ref_6","unstructured":"CDC (Center for Disease Control) (2020, December 23). Symptoms of Corona Virus, Available online: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/symptoms-testing\/symptoms.html."},{"key":"ref_7","unstructured":"WHO (World Health Organization) (2020, December 23). Coronavirus. Available online: https:\/\/www.who.int\/health-topics\/coronavirus#tab=tab_3."},{"key":"ref_8","unstructured":"CDC (Center for Disease Control) (2021, January 14). Coronavirus Disease 2019 (COVID-19): People with Certain Medical Condition, Available online: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/need-extra-precautions\/people-with-medical-conditions.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fneed-extra-precautions%2Fgroups-at-higher-risk.html."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jama.2020.24243","article-title":"All-Cause Excess Mortality and COVID-19\u2013Related Mortality Among US Adults Aged 25\u201344 Years, March\u2013July 2020","volume":"325","author":"Faust","year":"2021","journal-title":"JAMA"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/s41591-020-0965-6","article-title":"Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections","volume":"26","author":"Long","year":"2020","journal-title":"Nat. Med."},{"key":"ref_11","unstructured":"Cha, A.E. (2020, December 29). Forty Percent of People with Coronavirus Infections Have No Symptoms. Might They Be the Key to Ending the Pandemic?. Available online: https:\/\/www.washingtonpost.com\/health\/2020\/08\/08\/asymptomatic-coronavirus-covid\/."},{"key":"ref_12","unstructured":"Cha, A.E. (2020, December 29). Many People with the Coronavirus don\u2019t Show Symptoms. Researchers Want to Know Why. Available online: https:\/\/www.bostonglobe.com\/2020\/08\/08\/nation\/many-people-with-coronavirus-dont-show-symptoms-researchers-want-know-why\/."},{"key":"ref_13","unstructured":"Pattersson, H., Manley, B., and Hernandez, S. (2021, January 04). Tracking Covid-19\u2032s Global Spread. Available online: https:\/\/www.cnn.com\/interactive\/2020\/health\/coronavirus-maps-and-cases\/."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Miller, A., Reandelar, M.J., Fasciglione, K., Roumenova, V., Li, Y., and Otazu, G.H. (2020). Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: An epidemiological study. MedRxiv.","DOI":"10.1101\/2020.03.24.20042937"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1128\/JVI.02393-08","article-title":"CD4 T-Cell-Mediated Heterologous Immunity between Mycobacteria and Poxviruses","volume":"83","author":"Mathurin","year":"2009","journal-title":"J. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Zwerling, A., Behr, M.A., Verma, A., Brewer, T.F., Menzies, D., and Pai1, M. (2011). The BCG World Atlas: A Database of Global BCG Vaccination Policies and Practices. PLoS Med., 8.","DOI":"10.1371\/journal.pmed.1001012"},{"key":"ref_17","unstructured":"Keener, A.B., and Repurposed Remedy (2021, July 14). A 100-Year-Old Weapon against TB Shows Early Promise Against Multiple Diseases. Available online: https:\/\/dokumen.pub\/qdownload\/june-5-2021-sciencenews.html."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"17720","DOI":"10.1073\/pnas.2008410117","article-title":"BCG vaccine protection from severe coronavirus disease 2019 (COVID-19)","volume":"117","author":"Escobar","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e00907","DOI":"10.1128\/mBio.00907-20","article-title":"Could an Unrelated Live Attenuated Vaccine Serve as a Preventive Measure to Dampen Septic Inflammation Associated with COVID-19 Infection?","volume":"11","author":"Fidel","year":"2020","journal-title":"mBio"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cell.2020.08.051","article-title":"Activate: Randomized Clinical Trial of BCG Vaccination against Infection in the Elderly","volume":"183","author":"Tsilika","year":"2020","journal-title":"Cell"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e145157","DOI":"10.1172\/JCI145157","article-title":"BCG Vaccination History Associates with Decreased SARS-COV-2 Seroprevalence Across a Diverse Cohort of Health Care Workers","volume":"131","author":"Rivas","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_22","first-page":"1","article-title":"Anticipated reduction in COVID-19 mortality due to population-wide BCG vaccination: Evidence from Germany","volume":"44","author":"Nixon","year":"2021","journal-title":"Human Vacc. Immunother."},{"key":"ref_23","unstructured":"McLean, H.Q., Fiebelkorn, A.P., Temte, J.I., and Wallace, G.S. (2021, March 13). Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, Available online: https:\/\/www.cdc.gov\/mmwr\/pdf\/rr\/rr6204.pdf."},{"key":"ref_24","unstructured":"Lapid, N. (2021, March 14). Childhood Vaccine Linked to Less Severe COVID-19, Cigarette Smoke Raises Risk. Available online: https:\/\/www.reuters.com\/article\/us-health-coronavirus-science\/childhood-vaccine-linked-to-less-severe-covid-19-cigarette-smoke-raises-risk-idUSKBN2802LP."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e03447","DOI":"10.1128\/mBio.03447-20","article-title":"MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection","volume":"12","author":"Marakasova","year":"2021","journal-title":"mBio"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e02628","DOI":"10.1128\/mBio.02628-20","article-title":"Analysis of Measles-Mumps-Rubella (MMR) Titers of Recovered COVID-19 Patients","volume":"11","author":"Gold","year":"2020","journal-title":"mBio"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Root-Bernstein, R. (2020). Possible Cross-Reactivity between SARS-CoV-2 Proteins, CRM197 and Proteins in Pneumococcal Vaccines May Protect Against Symptomatic SARS-CoV-2 Disease and Death. Vaccines, 8.","DOI":"10.20944\/preprints202007.0141.v2"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Comunale, B.A., Engineer, L., Jiang, Y., Andrews, J.C., Liu, Q., Ji, L., Yurkovich, J.T., Comunale, R.A., and Xie, Q. (2021). Poliovirus Vaccination Induces a Humoral Immune Response that Cross Reacts with SARS-CoV-2. MedRxiv.","DOI":"10.1101\/2021.06.19.21257191"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41586-020-2550-z","article-title":"SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls","volume":"584","author":"Tan","year":"2020","journal-title":"Nature"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1038\/s41467-021-22036-z","article-title":"Exposure to SARS-CoV-2 generates T-cell memory in the absence of a detectable viral infection","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1164\/rccm.202005-1701LE","article-title":"COVID-19 severity correlates with weaker T-Cell immunity, hypercytokinemia, and lung epithelium injury","volume":"202","author":"Wang","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1186\/s13054-020-03120-0","article-title":"Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19","volume":"24","author":"Ni","year":"2020","journal-title":"Crit. Care"},{"key":"ref_33","unstructured":"Sriram, K., Insel, P., and Loomba, R. (2021, June 28). What is the ACE2 receptor, how is it connected to coronavirus and why might it be key to treating COVID-19?. The Experts Explain., Available online: https:\/\/theconversation.com\/what-is-the-ace2-receptor-how-is-it-connected-to-coronavirus-and-why-might-it-be-key-to-treating-covid-19-the-experts-explain-136928."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1113\/expphysiol.2007.040014","article-title":"Angiotensin-converting enzyme 2 gene targeting studies in mice: Mixed messages","volume":"93","author":"Gurley","year":"2008","journal-title":"Exp. Physiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.peptides.2014.07.002","article-title":"Angiotensin 1\u20137: A peptide for preventing and treating metabolic syndrome","volume":"59","author":"Santos","year":"2014","journal-title":"Peptides"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1111\/bph.15082","article-title":"A hypothesis for pathobiology and treatment of COVID-19: The centrality of ACE1\/ACE2 imbalance","volume":"177","author":"Sriram","year":"2020","journal-title":"Brit. Pharm. Soc."},{"key":"ref_37","first-page":"H137","article-title":"Biochemical evaluation of the renin-angiotensin system: The good, bad, and absolute?","volume":"310","author":"Chappell","year":"2016","journal-title":"Am. J. Physiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000108758","article-title":"Angiotensin-(1-7) prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive rats","volume":"28","author":"Benter","year":"2008","journal-title":"Am. J. Nephrol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1111\/j.1476-5381.2012.01905.x","article-title":"Angiotensin-(1-7) inhibits allergic inflammation, via the MAS1 receptor, through suppression of ERK1\/2- and NF-\u03baB-dependent pathways","volume":"166","author":"Renno","year":"2012","journal-title":"Brit. J. Pharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1152\/physrev.00023.2016","article-title":"The ACE2\/Angiotensin-(1-7)\/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7)","volume":"1","author":"Santos","year":"2018","journal-title":"Physiol. Rev."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41591-020-0868-6","article-title":"SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes","volume":"26","author":"Sungnak","year":"2020","journal-title":"Nat. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e2021450118","DOI":"10.1073\/pnas.2021450118","article-title":"Targeting transcriptional regulation of SARS-CoV-2 entry factors ACE2 and TMPRSS2","volume":"118","author":"Qiao","year":"2021","journal-title":"Proc. Nat. Acad. Sci. USA"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.mayocp.2020.06.018","article-title":"Targeting TMPRSS2 in SARS-CoV-2 Infection","volume":"95","author":"Baughn","year":"2020","journal-title":"Mayo Clin. Proc."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/d41586-020-03070-1","article-title":"Interferon deficiency can lead to severe COVID","volume":"587","author":"Meffre","year":"2020","journal-title":"Nature"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Sa Ribero, M., Jouvenet, N., Dreux, M., and Nisole, S. (2020). Interplay between SARS-CoV-2 and the type I interferon response. PLoS Pathog., 16.","DOI":"10.1371\/journal.ppat.1008737"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"eabd4585","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"key":"ref_49","first-page":"e01061","article-title":"A randomized clinical trial of the efficacy and safety of interferon \u03b2-1a in treatment of severe COVID-19","volume":"64","author":"Rahmani","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.3389\/fimmu.2020.01061","article-title":"Interferon -\u03b12b Treatment for COVID-19","volume":"11","author":"Qiang","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1089\/vim.2020.0076","article-title":"Protective Potentials of Type III Interferons in COVID-19 Patients: Lessons from Differential Properties of Type I- and III Interferons","volume":"34","author":"Jafarzadeh","year":"2021","journal-title":"Viral. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s12276-021-00592-0","article-title":"Type I and III interferon responses in SARS-CoV-2 infection","volume":"53","author":"Kim","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/infdis\/jiab288","article-title":"Type I, II, and III interferon signatures correspond to COVID-19 disease severity","volume":"224","author":"Kim","year":"2021","journal-title":"J. Infect. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1126\/science.abc3545","article-title":"Type III interferons disrupt the lung epithelial barrier upon viral recognition","volume":"369","author":"Broggi","year":"2020","journal-title":"Science"},{"key":"ref_55","unstructured":"Fliesler, N. (2021, September 05). Type III Interferon in COVID-19: Protective or Harmful?. 2020., Available online: https:\/\/answers.childrenshospital.org\/interferon-covid-19\/."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF00253067","article-title":"A toxicity study of recombinant interferon-gamma given by intravenous infusion to patients with advanced cancer","volume":"18","author":"Sriskandan","year":"1986","journal-title":"Cancer Chemother Pharm."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1126\/science.abe1107","article-title":"Preexisting and de novo humoral immunity to SARS-CoV-2 in humans","volume":"370","author":"Ng","year":"2020","journal-title":"Science"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ijid.2020.10.104","article-title":"High prevalenace of pre-existing serological cross-reactivity against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in sub-Sharan Africa","volume":"102","author":"Tso","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"ref_59","first-page":"101180","article-title":"High incidence of false-positive results of IgG antibody against SARS-CoV-2 with rapid immunochromatographic antibody test due to human common cold coronavirus infection","volume":"31","author":"Shibata","year":"2020","journal-title":"Respir. Med. Case Rep."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Girona-Alarcon, M., Bobillo-Perez, S., Sole-Ribalta, A., Hernandez, L., Guitart, C., Suarez, R., Balaguer, M., Francisco-Jose, C., and Jordan, I. (2021). The different manifestations of COVID-19 in adults and children: A cohort study in an intensive care unit. BMC Infect. Dis., 21.","DOI":"10.1186\/s12879-021-05786-5"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"108510","DOI":"10.1016\/j.clim.2020.108510","article-title":"Development of child immunity in the context of COVID-19 pandemic","volume":"217","author":"Kloc","year":"2020","journal-title":"Clin. Immunol."},{"key":"ref_62","unstructured":"CDC (Center for Disease Control) (2020, December 24). Polio Vaccination: What Everyone Should Know, Available online: https:\/\/www.cdc.gov\/vaccines\/vpd\/polio\/public\/index.html."},{"key":"ref_63","unstructured":"CDC (Center for Disease Control) (2020, December 27). Pneumococcal Vaccination: What Everyone Should Know, Available online: https:\/\/www.cdc.gov\/vaccines\/vpd\/pneumo\/public\/index.html."},{"key":"ref_64","first-page":"156","article-title":"Prevention of COVID-19 among older adults receiving pneumococcal conjugate vaccine suggests interaction between Streptococcus pneumoniae and SARS-CoV-2 in the respiratory tract","volume":"128","author":"Lewnard","year":"2021","journal-title":"J. Infect. Dis."},{"key":"ref_65","unstructured":"WHO (2021, September 06). The Effects of Virus Variants on COVID-19 Vaccines. Available online: https:\/\/www.who.int\/news-room\/feature-stories\/detail\/the-effects-of-virus-variants-on-covid-19-vaccines?gclid=Cj0KCQjw-NaJBhDsARIsAAja6dOyeZWwc31zI3NLSaIkNYJW51JTwwV20V3E8KRseBFHx0BjbjWW7aMaAgf-EALw_wcB."},{"key":"ref_66","unstructured":"CDC (Center for Disease Control) (2021, June 01). Smallpox, Available online: https:\/\/www.cdc.gov\/smallpox\/."},{"key":"ref_67","unstructured":"(2021, June 10). History of Polio. Available online: https:\/\/www.historyofvaccines.org\/timeline\/polio."}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/18\/18\/9785\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:01:06Z","timestamp":1760166066000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/18\/18\/9785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,17]]},"references-count":67,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2021,9]]}},"alternative-id":["ijerph18189785"],"URL":"https:\/\/doi.org\/10.3390\/ijerph18189785","relation":{},"ISSN":["1660-4601"],"issn-type":[{"type":"electronic","value":"1660-4601"}],"subject":[],"published":{"date-parts":[[2021,9,17]]}}}